Clinical trial
Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia
NCT06229860 is registered in ClinicalTrials.gov with University of California, Irvine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia
- Lead sponsor
- University of California, Irvine
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 25, 2024
- Completion date
- December 31, 2026
- Enrollment
- 75 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic myeloid leukemia, chronic phase chronic myelogenous leukemia